News | November 19, 2025
Sudeep Pharma eyes Rs. 895 crore fundraising from debut on bourses
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
The investment in land is Rs. 19.85 crore
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Subscribe To Our Newsletter & Stay Updated
